This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Psoriasis Vulgaris
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

A phase 3 trial comparing the efficacy and safety of LEO 90100 aerosol foam with the aerosol foam vehicle used twice weekly as long-term maintenance therapy in subjects with psoriasis vulgaris. A 12-month, international, multi-centre, randomised, vehicle controlled, double-blind, 2-arm, parallel group trial.

Provided treatments

  • Drug: LEO 90100 aerosol foam
  • Drug: LEO 90100 aerosol foam vehicle

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02899962. The sponsor of the trial is LEO Pharma and it is looking for 722 volunteers for the current phase.
Official trial title:
LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris